Shire Share Discussion Threads

[ruethewhirl] 25/4/2018 01:09

46 billion - is that 50 pounds per share?

Nice :)

[scothernman] 25/4/2018 01:05

FOrex Live News: Shire says willing to recommend revised Takeda proposal.regarding a possible offer for the Company The Board has indicated to Takeda that it would be willing to recommend the Revised Proposal to Shire shareholders subject to satisfactory resolution of the other terms of the possible offer, including completion of reciprocal due diligence by Shire on Takeda. Accordingly, the Board will engage in discussions with Takeda in relation to these terms.
GBP positive news as far as it goes. Still negotiation to be done, but Shire's Board saying its willing to recommend the bid subject to various conditions etc.
More:
extension of PUSU deadline to May 8th
revised proposal worth around 46bn GBP
Close in US from 163 at close to $172.5 after market close. Bodes well for open tommorow in UK

[philanderer] 25/4/2018 00:39

Best guess 4070p tomorrow.

4300p if Takeda ever complete this deal.

[spbcscw] 25/4/2018 00:20

£49 ..... that'll do nicely

[ny boy] 24/4/2018 23:43

I will be happy to take £44-45 this week, if it comes

Should be a cracking day for big pharmas with GSK reporting at midday as well.

[philanderer] 24/4/2018 23:21

That should flush out any other bidders ... that's if there are any ;-)

[ny boy] 24/4/2018 23:08

What’s tops likely on the official announcement?

[ny boy] 24/4/2018 22:59

Where are we now on the share price in London?

[scothernman] 24/4/2018 21:59

Today's Shire meeting report.....shire plc is at the center of one of the highest-profile takeover battles in the world right now. Its annual meeting in Dublin on Tuesday drew about 20 investors, two journalists and a couple of public relations advisers and was all over in 15 minutes.

Shareholders voted on all 20 resolutions and asked no questions from the floor at the Miesian Plaza on Baggot Street, located close to some of the city’s most famous bars. The board sat at one long table, facing three rows of seats for attendees. Many were empty.

The muted occasion perhaps reflects the disconnect between Shire’s U.S. operational center in Lexington, Massachusetts and its group headquarters that are spread over two relatively inconspicuous blocks in Dublin. A clutch of international drug companies have bases in Ireland, attracted by the nation’s tax structure.

Chairwoman Susan Kilsby acknowledged to the few gathered that shareholders were “acutely”; aware of the company’s “disappointing” share price performance in 2017 -- a 17 percent drop. Beyond that, she could say little new, as the board mulled a new offer by Japan’s Takeda Pharmaceutical Co., restricting what information could be given to investors.

With that, it was pretty much all over.

[swedeee] 24/4/2018 21:31

good stuff :-)

[scfc1] 24/4/2018 21:08

Up c4% after hours though...

[philanderer] 24/4/2018 21:01

3910p 'ish stateside close.

[dealy] 24/4/2018 19:10

Markets are so bad they should accept the offer. Together stronger

[podgyted] 24/4/2018 18:39

Possible announcement after US close.

[podgyted] 24/4/2018 18:38

Hopefully we'll have an acceptance in principle or a request for an extention of the deadline tomorrow.

Would think it may be pretty slow after that - conditions of the offer - due diligence etc - while before s/h vote IMO.

[montyhedge] 24/4/2018 16:13

hjs
Ok, lets hope your right, otherwise it down big time tomorrow.

[romeike] 24/4/2018 16:03

OK, you are right, they wanted to get to the pub.

[romeike] 24/4/2018 16:02

It means they have a lot on their plate, which is quite obvious, on top of this bid situation they have to present Q1 results on Thursday and prepare for the investor call, all on top of daily business. Executives having to work for their money - makes a change.